PROTHROMBIN GENE MUTATION ANALYSIS Test
Test Name: PROTHROMBIN GENE MUTATION ANALYSIS
Test Components: Price – 770.0 AED
Sample Condition: 3 mL (1.5 mL/min.) whole blood in 1 LavenderTop (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery: Sample Mon/Thu by 11 am; Report Wed/Sat
Method: Real Time PCR
Test Type: Thromboembolic disorders
Doctor: Hematologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
About the Prothrombin Gene Mutation Analysis Test
The Prothrombin Gene Mutation Analysis test is a genetic test used to detect a specific mutation in the prothrombin gene. This mutation, known as the prothrombin gene mutation or factor II mutation, is associated with an increased risk of blood clots, particularly in the veins (venous thromboembolism).
The test involves analyzing a blood sample to determine if the prothrombin gene mutation is present. The mutation is a change in the DNA sequence of the prothrombin gene, which leads to an increased production of prothrombin, a protein involved in blood clotting. This increased production of prothrombin can result in the formation of abnormal blood clots.
Who Should Take the Test?
The Prothrombin Gene Mutation Analysis test is typically ordered for individuals with a personal or family history of blood clots, especially if the clots occurred at a young age or without any known risk factors. It may also be ordered for individuals who have experienced recurrent blood clots or those who have had unexplained pregnancy complications, such as recurrent miscarriages or fetal growth restriction.
By identifying the presence of the prothrombin gene mutation, healthcare providers can better assess an individual’s risk of developing blood clots and determine appropriate treatment or preventive measures. Treatment may involve the use of anticoagulant medications to prevent clot formation or lifestyle modifications to reduce the risk of clotting.
It is important to note that the Prothrombin Gene Mutation Analysis test is not a routine screening test and is typically only ordered for individuals with specific risk factors or symptoms. The test results should be interpreted by a healthcare professional in the context of the individual’s medical history and other relevant factors.
| Test Name | PROTHROMBIN GENE MUTATION ANALYSIS Test |
|---|---|
| Components | |
| Price | 770.0 AED |
| Sample Condition | 3 mL (1.5mLmin.)whole blood in 1 LavenderTop (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Report Delivery | Sample Mon / Thuby 11 am;Report Wed/Sat |
| Method | Real Time PCR |
| Test type | Thromboembolic disorders |
| Doctor | Hematologist |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Test Details |
The Prothrombin Gene Mutation Analysis test is a genetic test used to detect a specific mutation in the prothrombin gene. This mutation, known as the prothrombin gene mutation or factor II mutation, is associated with an increased risk of blood clots, particularly in the veins (venous thromboembolism). The test involves analyzing a blood sample to determine if the prothrombin gene mutation is present. The mutation is a change in the DNA sequence of the prothrombin gene, which leads to an increased production of prothrombin, a protein involved in blood clotting. This increased production of prothrombin can result in the formation of abnormal blood clots. The Prothrombin Gene Mutation Analysis test is typically ordered for individuals with a personal or family history of blood clots, especially if the clots occurred at a young age or without any known risk factors. It may also be ordered for individuals who have experienced recurrent blood clots, or for those who have had unexplained pregnancy complications, such as recurrent miscarriages or fetal growth restriction. By identifying the presence of the prothrombin gene mutation, healthcare providers can better assess an individual’s risk of developing blood clots and determine appropriate treatment or preventive measures. Treatment may involve the use of anticoagulant medications to prevent clot formation or lifestyle modifications to reduce the risk of clotting. It is important to note that the Prothrombin Gene Mutation Analysis test is not a routine screening test and is typically only ordered for individuals with specific risk factors or symptoms. The test results should be interpreted by a healthcare professional in the context of the individual’s medical history and other relevant factors. |
